Skip to main content
User picture
Academic title: MSc.
Phone: +420 585632145, +420 585632066
Groups: IMTM, LEM, STAFF

About me

My main focus is use immunohistochemical methods and caplture laser microdissection in establishment of new diagnostic and prognostic markers in human and animal research. 

I also work as an occupational safety manager at the Institute of Molecular and Translational Medicine. I am responsible for the proper management of safety inspections of employees, training of employees in occupational safety and organization of the operating rules of the institute.

Journals

REISSIG, F., K. ZACHSLER, Z. NOVÝ, M. PETŘÍK, K. DVOŘÁKOVÁ BENDOVÁ, D. KURFÜRSTOVÁ, J. BOUCHAL, M. ĹUDIK, F. BRANDT, K. KOPKA, M. KHOYLOU, H. PIETZSCH, M. HAJDÚCH, C. MAMAT
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin. Theranostics. 2022, 12(17), 7203-7215, ISSN: 1838-7640, PMID: 36438496,
VIDLAŘOVÁ, M., E. BERTA, P. PRASIL, A. PROKOPOVÁ, S. GURSKÁ, M. KHOYLOU, A. ŘEHULKOVÁ, P. KOUŘILOVÁ, J. CHUDÁČEK, M. SZKORUPA, J. KLEIN, J. ŠKARDA, J. SROVNAL, M. HAJDÚCH
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival. Translational Lung Cancer Research. 2022, 11(10), 2040-2050, ISSN: 2218-6751, PMID: 36386452,
PFISTER, J., D. SUMMER, M. PETŘÍK, M. KHOYLOU, A. LICHNIUS, P. KAEOPOOKUM, L. KOCHINKE, T. ORASCH, H. HAAS, C. DECRISTOFORO
Hybrid Imaging of Aspergillus fumigatus Pulmonary Infection with Fluorescent, 68Ga-Labelled Siderophores. Biomolecules. 2020, 10(2), pii: E168, ISSN: 2218-273X, PMID: 31979017,  PDF.

Books & book chapters

DRÁBEK, J., J. BERKOVCOVÁ, P. DŽUBÁK, M. HAJDÚCH, M. KHOYLOU, V. KOUDELÁKOVÁ, J. SROVNAL, M. STAŇKOVÁ, R. TROJANEC
Detekce nádorových biomarkerů v molekulárně biologické laboratoři, 1. vyd, Olomouc, Univerzita Palackého v Olomouci, 2012, 144 s, Dedication: MOLONKOL CZ.1.07/2.3.00/09.0089, ISBN: 978-80-244-3002-7,

Intellectual property

METHOD OF DETERMINING SENSITIVITY OF PATIENTS WITH TUMOROUS DISEASE TO TREATMENT WITH HER-2 RECEPTOR INHIBITORS (Hajdúch)
  1. Patent: CZ 302709; Granted: 3.8.2011; Ownership: Palacky University Olomouc, Masaryk Memorial Cancer Institute Brno; Inventors: Hajdúch Marián, Dziechcarková Marta, Radová Lenka, Svoboda Marek
  2. Published Application PCT/CZ2009/000006 under WO2009/092338 (30.7.2009)
  3. Patent: US 8,465,936; Granted: 18.6.2013; Ownership: Palacky University Olomouc, Masaryk Memorial Cancer Institute Brno; Inventors: Hajdúch Marián, Dziechcarková Marta, Radová Lenka, Svoboda Marek
  4. Patent: JP 5295268; Granted: 21.6.2013; Ownership: Palacky University Olomouc, Masaryk Memorial Cancer Institute Brno; Inventors: Hajdúch Marián, Dziechcarková Marta, Radová Lenka, Svoboda Marek
  5. Patent: EP 2241890; Granted: 9.4.2014; Ownership: Palacky University Olomouc, Masaryk Memorial Cancer Institute Brno; Inventors: Hajdúch Marián, Dziechcarková Marta, Radová Lenka, Svoboda Marek

Status: Terminated

Master mentorship

Jenčíková Barbora

Expression of opioid receptors and its influence on the treatment of gastrointestinal cancer patients

Status: Graduated from 2015 to 2017.

Bachelor mentorship

Míšek David

Expression of matrix metalloproteinases in tubular adenomas compared to expression in colorectal carcinomas

Status: Graduated from 2015 to 2016.

Hrušková Eva B.Sc.

The role of metalloproteinases in the process of tumor progression in patients with colorectal carcinoma.

Status: Graduated from 2013 to 2013.

Jenčíková Barbora

Prognostic and predictive significance of matrix metalloproteinases in patients with colorectal cancer

Status: Graduated from 2013 to 2015.